Feinstein Institute scientists present data about glioblastoma at AACR Annual Meeting

April 4th, 2012
Scientists from the Feinstein Institute for Medical Research will present three abstracts about Glioblastoma multiforme (GBM), the most common and deadly adult brain cancer, at the American Association for Cancer Research (AACR) Annual Meeting to be held from Saturday through Wednesday (March 31- April 4) in Chicago, IL.

GBM is an incurable disease and patients who are diagnosed with GBM have approximately one year to live. Treatment for GBM can involve chemotherapy, radiation, radiosurgery, among a few other methods, but it's important to note that glioblastoma tumors spread very quickly and are highly resistant standard treatments such as chemotherapy and radiotherapy. This resistance often leads to tumor recurrence even after treatment.

A team of researchers at the Feinstein are presenting the following abstracts on this topic:

  • Abstract Number LB-503: "Pharmacological inhibition of microglia leads to increased survival in a murine model of glioblastoma multiforme in conjunction with ionizing radiation"
  • Ian S. Miller, PhD, Post-Doctoral research fellow at the Center for Oncology and Cell Biology at the Feinstein Institute, will present this data.
  • Abstract Number LB-515: "Guanine nucleotide exchange factor Dock7 expression is increased in human glioblastoma and mediates tumor cell invasion"
  • David W. Murray, senior research assistant at the Feinstein Institute, will present this data.
  • Abstract Number LB-516: "PDZ-RhoGEF promotes glioblastoma cell invasion, proliferation and survival"
  • Aneta Kwiatkowska, PhD, Post-Doctoral research fellow at the Feinstein Institute, will present this data.
All three of these abstracts will be present on Wednesday, April 04, from 8:00 am - 12:00 pm CT.

Provided by North Shore-Long Island Jewish (LIJ) Health System

This Phys.org Science News Wire page contains a press release issued by an organization mentioned above and is provided to you “as is” with little or no review from Phys.Org staff.

More news stories

CERN collides heavy nuclei at new record high energy

The world's most powerful accelerator, the 27 km long Large Hadron Collider (LHC) operating at CERN in Geneva established collisions between lead nuclei, this morning, at the highest energies ever. The LHC has been colliding ...

A new form of real gold, almost as light as air

Researchers at ETH Zurich have created a new type of foam made of real gold. It is the lightest form ever produced of the precious metal: a thousand times lighter than its conventional form and yet it is nearly impossible ...

Study suggests fish can experience 'emotional fever'

(Phys.org)—A small team of researchers from the U.K. and Spain has found via lab study that at least one type of fish is capable of experiencing 'emotional fever,' which suggests it may qualify as a sentient being. In their ...

New 'self-healing' gel makes electronics more flexible

Researchers in the Cockrell School of Engineering at The University of Texas at Austin have developed a first-of-its-kind self-healing gel that repairs and connects electronic circuits, creating opportunities to advance the ...

Aging star's weight loss secret revealed

A team of astronomers using ESO's Very Large Telescope has captured the most detailed images ever of the hypergiant star VY Canis Majoris. These observations show how the unexpectedly large size of the particles of dust surrounding ...